Wikipedia
ChromaDex is a publicly traded natural products company based in Irvine, California. The company is most well known for its industry standard phytochemical testing laboratories and catalogue. In cooperation with the University of Mississippi, the company is currently exploring the effects of pterostiibene on humans.
ChromaDex has licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line.
In 2010, ChromaDex won the North American Frost & Sullivan Award for Most Promising Ingredient of the Year for pTeroPure pterostilbene.
In 2016, ChromaDex achieved GRAS status for its patented nicotinamide riboside product, NIAGEN, which allows it to be marketed in the food and beverage industries. ChromaDex also initiated a 2nd human clinical trial on NIAGEN, to examine the benefits if taken daily for eight consecutive weeks. In addition, ChromaDex was named as part of the OTCQX Best 50.
American billionaire and pharmaceutical entrepreneur Phillip Frost owns approximately 19% of ChromaDex.